How T cells affect kidney function and blood pressure regulation
T cell homing to the kidney contributes to salt retention and blood pressure regulation
This study is looking at how certain immune cells in your body might affect high blood pressure and how your kidneys handle salt, with the hope of finding new ways to help people manage their hypertension better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-11073118 on NIH RePORTER |
What this research studies
This research investigates the role of immune cells, specifically CD8+ T cells, in regulating blood pressure and salt retention in the kidneys. The study aims to uncover the mechanisms behind the inappropriate activation of these T cells during hypertension, which may lead to persistent high blood pressure. By exploring how these immune cells infiltrate the kidneys and contribute to hypertension, the research seeks to identify new treatment strategies for managing this condition. Patients may benefit from insights that could lead to more effective therapies for hypertension.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from hypertension, particularly those who experience difficulty in managing their blood pressure.
Not a fit: Patients with hypertension that is well-controlled or those without a history of high blood pressure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve blood pressure control and reduce the recurrence of hypertension.
How similar studies have performed: Previous research has indicated that immune responses play a significant role in hypertension, suggesting that this approach may yield valuable insights.
Where this research is happening
Little Rock, United States
- Univ of Arkansas for Med Scis — Little Rock, United States (Active)
Researchers
- Principal investigator: Mu, Shengyu — Univ of Arkansas for Med Scis
- Study coordinator: Mu, Shengyu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.